Results     27-May-24
Announcements
Aurobindo Pharma consolidated net profit rises 79.50% in the March 2024 quarter
Sales rise 17.45% to Rs 7491.92 crore
Net profit of Aurobindo Pharma rose 79.50% to Rs 908.75 crore in the quarter ended March 2024 as against Rs 506.27 crore during the previous quarter ended March 2023. Sales rose 17.45% to Rs 7491.92 crore in the quarter ended March 2024 as against Rs 6378.67 crore during the previous quarter ended March 2023.

For the full year,net profit rose 64.62% to Rs 3172.97 crore in the year ended March 2024 as against Rs 1927.50 crore during the previous year ended March 2023. Sales rose 16.60% to Rs 28704.50 crore in the year ended March 2024 as against Rs 24617.13 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales7491.926378.67 17 28704.5024617.13 17
OPM %22.1615.62 -20.3015.06 -
PBDT1706.341075.63 59 6093.513857.08 58
PBT1352.01730.06 85 4571.852612.50 75
NP908.75506.27 79 3172.971927.50 65

Previous News
  Aurobindo Pharma receives USFDA approval for Cephalexin Tablets
 ( Corporate News - 01-Oct-24   16:30 )
  Volumes jump at Interglobe Aviation Ltd counter
 ( Hot Pursuit - 01-Oct-24   11:00 )
  Aurobindo Pharma slides after arm’s Telangana facility gets 10 USFDA observations
 ( Hot Pursuit - 30-Sep-24   14:34 )
  USFDA conducts inspection of Apitoria Pharma's unit II
 ( Corporate News - 30-Sep-24   14:32 )
  Aurobindo Pharma Ltd down for fifth straight session
 ( Hot Pursuit - 20-Sep-24   13:35 )
  Auro Pharma arm gets EIR from USFDA for AP facility
 ( Hot Pursuit - 18-Sep-24   12:07 )
  Eugia Steriles receives concludes UFDA inspection of its new injectable facility
 ( Corporate News - 18-Sep-24   11:02 )
  LIC pares stake in Aurobindo Pharma
 ( Hot Pursuit - 14-Sep-24   15:16 )
  Nifty above 25,050 mark; pharma shares advance
 ( Market Commentary - Mid-Session 11-Sep-24   12:34 )
  Aurobindo Pharma arm gets USFDA nod for anesthetic drug
 ( Hot Pursuit - 11-Sep-24   12:26 )
  Eugia Steriles receives its first product approval from USFDA for Lidocaine Hydrochloride Injection
 ( Corporate News - 11-Sep-24   12:15 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top